| Status | Study |
| Not yet recruiting |
Study Name: Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia Condition: Anemia, Aplastic Date: 2016-07-26 Interventions: Drug: rhTPO rhTPO |
| Active, not recruiting |
Study Name: Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Condition: Aplastic Anemia Date: 2016-05-09 Interventions: Biological: Romiplostim Weekly SC administration |
| Recruiting |
Study Name: Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) Condition: Anemia, Aplastic Date: 2016-02-29 Interventions: Drug: Eltrombopag |
| Recruiting |
Study Name: Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia Condition: Severe Aplastic Anemia Date: 2015-03-25 Interventions: Drug: Rabbit antithymoglobulin (ATG) |
| Recruiting |
Study Name: Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia Condition: Aplastic Anemia Date: 2014-01-02 Interventions: Drug: ATG-fresenius we will create 2 arms as per randomiza |
| Withdrawn |
Study Name: Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia Condition: Aplastic Anemia Date: 2013-11-21 Interventions: Drug: cyclophosphamide,cyclosporine A Drug,cyclophosphamid |
| Completed |
Study Name: Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients Condition: Aplastic Anemia Date: 2013-03-05 Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A) |
| Withdrawn |
Study Name: Alemtuzumab and Rituximab in Aplastic Anemia Condition: Aplastic Anemia Date: 2011-07-29 Interventions: Drug: Alemtuzumab and Rituximab |
| Completed |
Study Name: Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia Condition: Aplastic Anemia Date: 2011-02-16 Interventions: Biological: Intravenous bone marrow mesenchymal stem cells infusion After standard immunosuppressive the |
| Suspended |
Study Name: Alefacept in Patients With Relapsed/Refractory Aplastic Anemia Condition: Aplastic Anemia Date: 2010-12-20 Interventions: Drug: Alefacept Dose Escalation Schedule |